| Financial Year |
March 31 2023 |
| Monetary Funds |
1,565,004,180.64 |
| Held-for-trading Financial Assets |
79,394.44 |
| Notes Receivable |
-- |
| Accounts Receivable |
99,013,080.43 |
| Advances to Suppliers |
36,694,464.47 |
| Other Receivables |
18,664,227.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,487,183,104.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
129,432,967.99 |
| Total Current Assets |
3,395,207,247.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
98,756,063.34 |
| Investment Properties |
85,669,585.89 |
| Fixed Assetes |
8,772,127,430.46 |
| Under-construction Projects |
2,669,908,601.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,229,952,150.96 |
| R&D expenses |
25,553,562.71 |
| Goodwill |
39,434,160.32 |
| Long-Term Deferred and Prepaid Expenses |
259,645,700.23 |
| Deferred Income Tax Assets |
110,315,263.27 |
| Other Non-Current Assets |
65,391,796.44 |
| Sub-Total of Non-Current Assets |
23,395,800,176.57 |
| Total Assets |
26,791,007,423.70 |
| Short-Term Loans |
271,856,017.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,388,973,043.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,690,859.86 |
| Taxes Payable |
254,007,616.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
340,207,237.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,528,553,119.35 |
| Other Current Liabilities |
20,655,186.31 |
| Sub-Total of Current Liabilities |
4,060,258,514.41 |
| Long-term Loans |
3,663,218,904.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
934,740,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
274,527,330.42 |
| Deferred Income Tax Liabilities |
642,895.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,936,491,838.83 |
| Total Liabilities |
8,996,750,353.24 |
| Paid-In Capital(Or Share Stock) |
5,091,291,568.00 |
| Capital Surplus |
8,183,519,937.80 |
| Surplus Reserve |
1,145,861,850.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,269,688,019.97 |
| Minority Stockholder's Interest |
2,304,820,056.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,489,437,013.58 |
| Owner's Equity（Stockholder's Equity） |
17,794,257,070.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,791,007,423.70 |
